Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-11-18Clinical Trial Update: FOLFIRINOX + NIS793 in Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating the combination of FOLFIRINOX and NIS793 in pancreatic cancer has been terminated.
-
CLINICAL_TRIALS withdrawal · 2025-05-25Clinical Trial Update: Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
The pancreatic cancer risk model and biomarker testing trial (NCT05287347) in a high-risk cohort has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-08-15Clinical Trial Update: CAPEcitabine eXtension of Adjuvant Therapy for Pancreatic Adenocarcinoma: (CAPE-X) [Phase 2]
A Phase 2 trial (CAPE-X) evaluating CAPEcitabine as adjuvant therapy for pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-05-26Clinical Trial Update: Trial of Carbon Ion Versus Photon Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer [Phase 3]
Phase 3 trial comparing carbon ion radiotherapy to photon radiotherapy for locally advanced, unresectable pancreatic cancer has been withdra…
-
CLINICAL_TRIALS withdrawal · 2021-03-19Clinical Trial Update: Eus-guided Cryothermal Ablation in Stage III Pancreatic Adenocarcinoma [Phase 3]
Phase 3 trial of eus-guided cryothermal ablation in pancreatic adenocarcinoma was withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-10-06Clinical Trial Update: Safety Study of Adjuvant Gemcitabine Started One Week After Laparoscopic Distal Pancreatectomy for Adenocarcinoma [Phase 2]
A Phase 2 safety trial of adjuvant gemcitabine after laparoscopic distal pancreatectomy for pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-04-03Clinical Trial Update: Cvac as Maintenance Treatment Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas [Phase 2]
A Phase 2 trial of Cvac as maintenance therapy for patients with resected Stage I or Stage II pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-08-14Clinical Trial Update: Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 study of CPI-613 (devimistat) with or without gemcitabine for metastatic pancreatic adenocarcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-22Clinical Trial Update: Pancreatic Enzyme Suppletion in Pancreatic Cancer [Phase 4]
A Phase 4 trial evaluating pancreatic enzyme supplementation for pancreatic adenocarcinoma has been withdrawn.